Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

被引:335
|
作者
Yan, MH
Brady, JR
Chan, B
Lee, WP
Hsu, B
Harless, S
Cancro, M
Grewal, IS
Dixit, VM
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[3] Univ Penn, Sch Med, Grad Program Immunol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S0960-9822(01)00481-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BLyS (also called BAFF, TALL-1, THANK, and zTNF4), a TNF superfamily member, binds two receptors, TACI and BCMA, and regulates humoral immune responses [1-7]. These two receptors also bind APRIL [7-10], another TNF superfamily member. The results from TACI(-/-) and BCMA(-/-) mice suggest the existence of additional receptor(s) for BLyS. The TACI knockout gives the paradoxical result of B cells being hyperresponsive, suggesting an inhibitory role for this receptor [11, 12], while BCMA null mice have no discernable phenotype [13]. Here we report the identification of a third BLyS receptor (BR3; BLyS receptor 3). This receptor is unique in that, in contrast to TACI and BCMA, BR3 only binds BLyS. Treatment of antigen-challenged mice with BR3-Fc inhibited antibody production, indicating an essential role for BLyS, but not APRIL, in this response. A critical role for BR3 in B cell ontogeny is underscored by our data showing that the BR3 gene had been inactivated by a discrete, approximately 4.7 kb gene insertion event that disrupted the 3' end of the BR3 gene in A/WySnJ mice, which lack peripheral B cells.
引用
收藏
页码:1547 / 1552
页数:6
相关论文
共 50 条
  • [31] IDENTIFICATION OF FELINE BLOOD LYMPHOCYTE-B AND LYMPHOCYTE-T BY CELL ELECTROPHORESIS
    DUMONT, F
    REICHART, E
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1979, 2 (01) : 23 - 30
  • [32] B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance
    Mueller, N.
    Hillebrand, S.
    Schulte, D. M.
    Tuerk, K.
    Neumann, K.
    Hampe, J.
    von Kampen, O.
    Brosch, M.
    von Schoenfels, W.
    Ahrens, M.
    Zeuner, R.
    Schroeder, J. O.
    Blueher, M.
    Schreiber, S.
    Laudes, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [33] Simplified T & B lymphocyte enumeration on a novel cell analyzer
    Clor, Julie
    Gillis, Katherine
    Tyagarajan, Kamala
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [34] A case of severe B cell deficiency after allogeneic stem cell transplantation
    Takahashi, T
    Chiba, S
    Matsumura, T
    Hirai, H
    BONE MARROW TRANSPLANTATION, 2002, 30 (06) : 397 - 400
  • [35] A case of severe B cell deficiency after allogeneic stem cell transplantation
    T Takahashi
    S Chiba
    T Matsumura
    H Hirai
    Bone Marrow Transplantation, 2002, 30 : 397 - 400
  • [36] B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
    Vendel, Andrew C.
    Calemine-Fenaux, Jill
    Izrael-Tomasevic, Anita
    Chauhan, Vandana
    Arnott, David
    Eaton, Dan L.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (03): : 1509 - 1517
  • [37] B-cell antigen receptor competence regulates B-lymphocyte selection and survival
    Buhl, AM
    Nemazee, D
    Cambier, JC
    Rickert, R
    Hertz, M
    IMMUNOLOGICAL REVIEWS, 2000, 176 : 141 - 153
  • [38] Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines
    Kar-Tong Tan
    Ling-Wen Ding
    Qiao-Yang Sun
    Zhen-Tang Lao
    Wenwen Chien
    Xi Ren
    Jin-Fen Xiao
    Xin Yi Loh
    Liang Xu
    Michael Lill
    Anand Mayakonda
    De-Chen Lin
    Henry Yang
    H. Phillip Koeffler
    BMC Cancer, 18
  • [39] Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: A novel mechanism for regulating B cell signaling
    Kumanogoh, A
    Watanabe, C
    Lee, I
    Wang, XS
    Shi, W
    Araki, H
    Hirata, H
    Iwahori, K
    Uchida, J
    Yasui, T
    Matsumoto, M
    Yoshida, K
    Yakura, H
    Pan, C
    Parnes, JR
    Kikutani, H
    IMMUNITY, 2000, 13 (05) : 621 - 631
  • [40] Early B cell developmental impairment with progressive B cell deficiency in NFKB2 mutated CVID disease without autoimmunity
    Lougaris, Vassilios
    Moratto, Daniele
    Baronio, Manuela
    Lorenzini, Tiziana
    Rossi, Stefano
    Gazzurelli, Luisa
    Bondioni, Maria Pia
    Plebani, Alessandro
    CLINICAL IMMUNOLOGY, 2019, 205 : 153 - 155